Inhibitor Therapeutics, Inc. (HPPI) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Total revenues	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth	32612.1%
Cost of goods sold	0.0	0.0	-1.1	0.0	0.0	0.0	0.0	0.0
Gross profit	13.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0
Gross margin	100.0%	0.0%
Selling, general and administrative [+]	0.7	0.3	0.9	1.5	1.9	2.9	4.4	2.3
General and administrative	0.7	0.3	0.9	1.5	1.9	2.9	4.4	2.3
Other selling, general and administrative
Research and development	0.0	0.0	0.2	1.2	2.6	2.2	2.6	1.7
Other operating expenses	0.7		1.1
EBITDA [+]
Depreciation and amortization
EBIT [+]	12.3	-0.3	-1.1	-2.7	-4.6	-5.1	-7.0	-3.9
EBIT growth	-3877.7%	-69.3%	-61.5%	-39.8%	-10.8%	-27.1%	77.8%	0.3%
EBIT margin	90.3%	-782.2%
Non-recurring items [+]	13.0
Legal settlement	13.0
Interest income, net [+]	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest expense	0.0	0.0
Interest income			0.0	0.0	0.0	0.0	0.0
Other income (expense), net	12.8	0.0
Pre-tax income	12.2	-0.3	-1.1	-2.7	-4.6	-5.1	-7.0	-3.9
Income taxes	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	11.9	-0.5	-1.3	-2.9	-4.7	-5.1	-7.0	-3.9
Net margin	87.6%	-1198.6%

Basic EPS [+]	$0.03	$0.00	$0.00	($0.01)	($0.01)	($0.01)	($0.02)	($0.02)
Growth	-2555.7%	-60.8%	-57.3%	-37.8%	-8.5%	-42.6%	42.8%	-59.0%
Diluted EPS [+]	$0.03	$0.00	$0.00	($0.01)	($0.01)	($0.01)	($0.02)	($0.02)
Growth	-2545.0%	-60.8%	-57.3%	-37.8%	-8.5%	-42.6%	42.8%	-59.0%

Dividends per share [+]				$0.00
Growth			-100.0%

Shares outstanding (basic) [+]	366.2	376.2	371.9	370.4	369.8	366.6	288.8	232.6
Growth	-2.7%	1.2%	0.4%	0.2%	0.9%	27.0%	24.1%	142.6%
Shares outstanding (diluted) [+]	367.8	376.2	371.9	370.4	369.8	366.6	288.8	232.6
Growth	-2.3%	1.2%	0.4%	0.2%	0.9%	27.0%	24.1%	142.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.